The Critical Impact of Regulatory Changes on Biomedical Innovation

This chapter explores the impact of recent regulatory changes on the biomedical and pharmaceutical industries, highlighting the tensions between national pride and the risk to medical innovation. It draws historical parallels to funding cuts from past administrations, raising concerns about the future of research and development.